The proposed law would allow the government to determine the price of a patented medicine based on whether the buyers have “economic accessibility.”

“We’ve got to do something,” said Tom Leek, the Republican lawmaker who introduced the House version of the legislation in Florida.

Karuna Therapeutics has pulled in $68 million in venture capital to advance clinical development of a radically different drug for schizophrenia.

Few pieces of medical advice have been so consistent for so long, and so ignored, as the admonition not to use foreign objects to remove earwax.

Scott Gottlieb will be missed as head of the FDA. But the FDA staff and the leadership of HHS won't let his policies be undermined or abandoned.

The drug reduced low-density-lipoprotein cholesterol by more than 17 percent in 12 weeks and sustained those results for a full year, according to new data.

As researchers compare liquid biopsy with traditional biopsies for cancer, they need to include patients' perspectives on the tests, not just effectiveness.

China is eager to compete with Western nations to develop cancer immunotherapies, but critics say the effort has spawned a feverish medical gold rush.

Dozens of companies already use the name Haven, including some that deliver or facilitate health services, according to a review of trademark registrations.

Its shares are down 25 percent from their October 2018 initial public offering, and the company has a market capitalization of just $89 million.

Apple is teaming with J&J to a conduct a study of 180,000 people over the age of 65 to get a better understanding of the Apple Watch's impact on health.

But the new results don’t tell us much about whether anyone should buy an Apple Watch, or whether the device is good for the population at large.

A feud has broken out between the Coalition for Epidemic Preparedness Innovations and Doctors Without Borders about equitable access to treatments.

Doctors in Brazil are testing the skin of the fish tilapia as a bandage for second- and third-degree burns — a innovation that arose from an unmet need.

CDC Director Robert Redfield offered a bleaker projection than one issued earlier by the director-general of the World Health Organization.

Congress’ Medicare advisers are chiding lawmakers for a change they made to the Medicare prescription drug program’s so-called donut hole last year.

All seven execs maintained their companies had never withheld samples, but a FDA list shows generics complained that Pfizer and AstraZeneca had done so.

The Match, which places half of U.S. medical school graduates in their first-choice programs, is being threatened by the flood of residency applications.

The Apple Watch can detect atrial fibrillation. But it's even more likely to raise false alarms, which can have harmful consequences.

At the conference, investors and doctor-specialists critiqued both approved and experimental drugs across nearly two dozen disease areas.

The ICU staple has recently spiked in price. There's a cheaper, compounded alternative — but its at the center of a thicket of lawsuits and regulations.

WHO Director-General Tedros Adhanom Ghebreyesus said that health officials are making progress against the virus, even as violence is making the job harder.

Commonly prescribed pills are mostly made up of ingredients that have little to do with the condition being treated, according to a new study.

What made Perlara unusual were its partnerships: The biotech teamed up with rare-disease focused patient advocacy groups.